|
 |
Can we escape natural history? A new look at HDL in coronary artery disease
S Gielen... - Heart, 2011 - heart.bmj.com1. Correspondence to Dr Stephan Gielen, Assistant Professor of Medicine, Heart Center Leipzig, University Hospital, Department of Internal Medicine/Cardiology, Struempellstrasse 39, Leipzig 04289, Germany; stephan. gielen {at} medizin. uni-leipzig. de
In this issue, Seo et al, on behalf of all participants in the COACT (Catholic University of Korea–percutaneous coronary intervention) registry, report that after placement of a drug-eluting stent in patients with coronary artery disease (CAD) and well controlled low-density lipoprotein (LDL-C) serum levels below 100 mg/dl, the high-density lipoprotein (HDL-C) serum concentrations remain a significant prognostic indicator of future cardiovascular events.1 The authors dichotomised the patient cohort according to HDL-C levels (40 mg/dl for men or 50 mg/dl for women) and compared major adverse cardiovascular event rates (MACE). Patients with low HDL-C levels (>
Free archive The full back archive is now available for Heart. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1. Register to access the free archive >>
More Details:
Can we escape natural history? A new look at HDL in coronary artery disease |
|
|
